FDA's Top Drug Regulator to Retire Amid Agency Turmoil
TL;DR
Richard Pazdur, the top FDA drug regulator, plans to retire just weeks after starting the job, amid concerns over the agency's legal and procedural approaches to drug approvals, contributing to recent instability at the FDA.
- Top FDA drug regulator plans to depart weeks into job The Washington Post
- FDA drug chief signals possible exit as agency turmoil deepens The Guardian
- The FDA’s top drug regulator submits his resignation to the agency Politico
- Pazdur to retire weeks after assuming leadership of CDER FirstWord Pharma
- US FDA's newly appointed drugs chief set to retire Reuters
Want the full story? Read the original reporting
Read on The Washington Post